Exosome Diagnostics

About:

Exosome Diagnostics develops and commercializes blood-based cancer molecular diagnostics for patient stratification and disease monitoring.

Website: http://www.exosomedx.com

Twitter/X: ExosomeDx

Top Investors: Forbion Capital Partners, b2venture, Qiagen, Tiger Management Corporation, Tiger Infrastructure Partners

Description:

Exosome Diagnostics is developing biofluid-based molecular diagnostic tests for use in personalized medicine. Exosomes and other microvesicles are shed into all biofluids, including blood, urine and cerebrospinal fluid, forming a highly enriched source of intact, disease-specific nucleic acids. The Company's proprietary exosome technology makes use of this natural enrichment to achieve high sensitivity and specificity for rare gene transcripts and the expression of genes responsible for cancers and other diseases.